1. Homepage
  2. Equities
  3. South Africa
  4. Johannesburg Stock Exchange
  5. Discovery Limited
  6. News
  7. Summary
    DSY   ZAE000022331

DISCOVERY LIMITED

(DSY)
  Report
End-of-day quote Johannesburg Stock Exchange  -  05-16
138.98 ZAR   -0.39%
05/16GLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
05/06Discovery Limited and Discovery Life Limited Announce Board and Committee Changes
CI
04/28DISCOVERY : Disclosure of significant holding of Discovery ordinary shares
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Discovery : highlights significant progress in implementation of mandatory vaccination policy

11/30/2021 | 11:21am EDT
  • On 3 September 2021, Discovery announced its mandatory vaccination policy for South Africa-based employees
  • Staff vaccination rates have climbed from 22% at start of September to 94% by 30 November
  • Across all main categories, including sex, age and seniority, more than 90% of staff are vaccinated
  • Vaccination rates projected to reach levels greater than 97% before the peak of fourth wave, in early 2022

Vaccination mandate consistent with Discovery's core purpose to make people healthier and to enhance and protect their lives

On 3 September 2021, Discovery announced its intention to implement a mandatory COVID-19 vaccination policy, effective 1 January 2022 for South Africa-based employees; with Discovery premises to be vaccinated-only zones.

When the mandate was announced, 22% of the organisation's 11 000-strong employees were vaccinated. Twelve weeks later, and 94% of staff have been vaccinated.

Staff vaccination is projected to reach levels greater than 97% before the peak of fourth wave in early 2022. This is likely if 40% of employees who have lodged objections to vaccination decided to be vaccinated, and if 63% of those who have said they plan to be vaccinated carry through with their plans.

Why introduce a mandatory vaccination policy?

"We debated a move to mandatory COVID-19 vaccination at length and sought wide-ranging input externally and internally," says Discovery Group CEO Adrian Gore. "Ultimately, as a science-led organisation, we felt a strong moral imperative to implement a mandate, given the need to curb the loss of life and the indisputable evidence that COVID-19 vaccines protect people from serious COVID-19 illness and death. The mandate is at the heart of our core purpose to make people healthier and to enhance and protect their lives."

Discovery's Mandatory Vaccination Policy takes the following into account:

  1. The COVID-19 pandemic is an unprecedented tragedy. "Based on excess deaths data published by the SA Medical Research Council (SAMRC), Discovery Health estimates that there have been more than 242,000 deaths in South Africa due to COVID-19 since May 2020. Our modelling assumes that only 90% of the excess deaths published by the SAMRC are related to COVID-19. More than 14,000 Discovery Health administered scheme members have died, and we have experienced devastating loss of life in our own organisation with 22 staff deaths," explains Gore.
  2. A wealth of credible research and global evidence from leading academic institutions conclusively demonstrates that COVID-19 vaccination is safe and effective. Furthermore, Discovery Health recently shared its data analysis of vaccine effectiveness (data from 1.2 million administered scheme members) in the context of the Delta variant of the SARS-CoV-2 virus. This analysis found that (relative to the unvaccinated), fully (Pfizer-BioNTech) vaccinated individuals experience a 79% lower risk of COVID-19 infection, 92% lower risk of hospitalisation and 94% lower risk of mortality 14-days post second-dose vaccination.
  3. Vaccination is a public health imperative both in slowing the spread of infection and rate at which new variants emerge. "Available data showslower rates of infection, severe disease and death in populations with high rates of vaccination. By slowing the spread of infection, we also reduce the chances of mutation and potential emergence of new variants," adds Gore.
  4. Vaccine supply is no longer the dominant constraint - overcoming hesitancy is. "At present, hesitancy is a key driver of low demand for COVID-19 vaccination," adds Gore. "We could vaccinate 80% of our population with Johnson & Johnson and Pfizer-BioNTech vaccine stock we have available. However, at present, national vaccine supply and capacity to vaccinate far exceeds demand for vaccination, particularly among younger age groups."
  5. Modelling shows fourth wave likely in December 2021; extent of wave shows sensitivity to vaccine uptake. "Discovery Health has run modelling around COVID-19 related deaths across various scenarios," says Gore. "A medium scenario assumes about 35% of the population is vaccinated by the end of 2021, and that vaccination rates plateau from there. In this case, between June 2021 and June 2022 (taking the third and fourth waves into account) South Africa experiences a further 16 000 excess deaths because of the pandemic. In the total absence of COVID-19 vaccines there would be a further 55 000 deaths over this time frame, showing the potentially significant toll of the pandemic without vaccination.

"There are indications that the looming fourth wave will be driven by the newly identified omicron variant of concern. While there is limited data around this variant at present, we do know that it exhibits extensive mutations in the spike protein alluding to its potentially increased transmissibility. Vaccination remains key to mitigating against severe illness and death in this regard."

Mandatory vaccination policy designed with specific principles in mind

Discovery's mandatory vaccination policy has been implemented in line with the following four principles:

  1. Ensuring mutual respect between employer and employee and in alignment with our values as an organisation.
  2. Balancing the individual rights and liberties of all employees (vaccinated and unvaccinated) with the operational and broader stakeholder obligations of the business.
  3. Regular and proactive discussion and engagement with employees to discuss and refine the implementation of the policy and to provide information and support. This includes a wide array of educational resources made available to staff in recent months, as well as being afforded the opportunity to consult with clinical experts, health professionals, and Discovery and human resources leaders as needed, to encourage staff to make informed decisions around being vaccinated for COVID-19. The objective is to offer employees all necessary support and information so that employees vaccinate voluntarily, and the mandate becomes nothing more than a filed policy come the new year."
  4. A structured process in place to consider objections to vaccination based on constitutional rights and to ensure a concerted effort to explore reasonable accommodation if required.

Gore adds: "At present, 583 employees are not vaccinated. Within this group, approximately 240 employees plan to vaccinate prior to the end of the year, and approximately 330 members of staff have lodged written objections to the mandatory vaccination policy.

A collective response is key to saving lives and to accelerating our economic recovery

"We are a data-driven and fact-based organisation with all of our decision made on the basis of rigorous analysis and scientific evidence," says Gore.

"Our experience so far shows that a mandatory vaccination policy works; and is key to accelerating vaccination take-up. As we move into a third year of the COVID-19 pandemic, we must do everything possible to prevent further disease and death and get the economy moving again. Our hope is that other organisations will follow suit, with a profound systemic impact on vaccination take-up."

Please see below link to media session hosted on 30 November 2021

Topic: Adrian Gore provides an update

Start Time: Nov 30, 2021 01:15 PM

Meeting Recording:

https://dsycloud.zoom.us/rec/share/_jV8YofypgDs8qsxLUTDyNLq1r6ZCWBfABZpqoymmTJ9A4W3jorH7bW1bJ57VgIG.JZmqDzA97aNmT8CB

Access Passcode: ^=M^+L9b


Disclaimer

Discovery Limited published this content on 30 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 November 2021 16:20:10 UTC.


© Publicnow 2021
All news about DISCOVERY LIMITED
05/16GLOBAL MARKETS LIVE : Pfizer, Tesla, Holcim, Novartis, Ford...
05/06Discovery Limited and Discovery Life Limited Announce Board and Committee Changes
CI
04/28DISCOVERY : Disclosure of significant holding of Discovery ordinary shares
PU
04/25DISCOVERY : Health Medical Scheme offers members the first and only Shari'ah Compliant arr..
PU
04/22DISCOVERY : Paymenow adds PEP, NetcarePlus and Discovery Health to its value-added service..
PU
04/22MARKETSCREENER’S WORLD PRESS REVIEW : April 22, 2022
04/11GLOBAL MARKETS LIVE : Societe Generale, Airbus, Amazon, Alphabet, Twitter...
04/08DISCOVERY : Dealings in securities by a director
PU
04/08DISCOVERY : Appointment of an independent non-executive director to the board
PU
04/07MARKETSCREENER'S WORLD PRESS REVIEW : April 7, 2022
More news
Financials
Sales 2022 52 840 M 3 315 M 3 315 M
Net income 2022 6 407 M 402 M 402 M
Net Debt 2022 20 267 M 1 272 M 1 272 M
P/E ratio 2022 14,0x
Yield 2022 0,38%
Capitalization 91 296 M 5 728 M 5 728 M
EV / Sales 2022 2,11x
EV / Sales 2023 2,08x
Nbr of Employees -
Free-Float 79,6%
Chart DISCOVERY LIMITED
Duration : Period :
Discovery Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DISCOVERY LIMITED
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 138,98 ZAR
Average target price 200,00 ZAR
Spread / Average Target 43,9%
EPS Revisions
Managers and Directors
Adrian Gore Group Chief Executive Officer & Executive Director
Deon Marius Viljoen Chief Financial Officer & Executive Director
Mark Edward Tucker Chairman
Thabane Vincent Maphai Independent Non-Executive Director
Sindiswa Victoria Zilwa Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
DISCOVERY LIMITED-3.20%5 728
AXA-9.93%59 369
METLIFE, INC.4.00%52 850
PRUDENTIAL FINANCIAL, INC.-3.95%38 985
AFLAC INCORPORATED-1.97%36 872
PRUDENTIAL PLC-20.24%34 698